MarketScreener Strategies COSMO Pharmaceuticals SA Swiss Exchange
Equities
LU1202320294
End-of-day quote
Other stock markets
|
||
- CHF | - |
|
Jun. 18 | Switzerland's Cosmo Pharmaceuticals Receives Drug Registration Certificate for Lumeblue in China | MT |
Jun. 03 | Cosmo Pharmaceuticals Swings to Loss in FY23; Revenue Down | MT |
- Stock Market
- Equities
- COPN Stock
- Stock
- News COSMO Pharmaceuticals SA
- MarketScreener Strategies